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The incidence of systemic microbial infections has increased
severely due to the increase of immunocompromised hosts.
The increasing predominance of microbial resistance to huge
antibiotics is also becoming a concern. Consequently, the
expensive treatment, toxicity and drug-resistance pose newing Saud University.
ial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
10.1016/j.arabjc.2013.07.029
2 S. Tahlan et al.conundrum insisting constant renewed efforts in the develop-
ment of new classes of antimicrobials with more speciﬁc action
(Amir et al., 2008).
Cancer remains one of the leading causes of death in the
world and as a result, there is a pressing need for the develop-
ment of novel and effective treatments. Currently, combina-
tion of chemotherapy with different mechanisms of action is
one of the methods that are being adopted to treat cancer.
Therefore, a single molecule containing more than one phar-
macophores, each with different modes of action may be ben-
eﬁcial for the treatment of cancer (Kamal et al., 2008).
1,2,4-Triazoles and their heterocyclic derivatives represent
an interesting class of compounds that possesses a wide spec-
trum of biological activities. A large number of 1,2,4-triazole
containing ring systems exhibited antibacterial, antifungal,
antitubercular, analgesic, anti-inﬂammatory, anticancer, anti-
convulsant, antiviral, insecticide and antidepressant activities
(Guzeldemirci and Kucukbasmaci, 2009).
Quantitative structure–activity relationships (QSARs), an
important area of chemometrics have been widely utilized to
study the relationship between chemical structures and biolog-
ical or other functional activities. QSAR has become increas-
ingly helpful in understanding many aspects of chemical–
biological interactions in drug and pesticide research as well
as in many other areas (Yu et al., 2009).
Schiff bases are considered as a very important class of or-
ganic compounds which have wide applications in many bio-
logical aspects. Many Schiff bases containing 1,2,4-triaole
moiety exhibit antibacterial, antifungal and antitumor activi-
ties. Metal complexes of some Schiff bases are used as model
molecules for biological oxygen carrier systems. Transition
metal complexes of tetra dentate Schiff base ligands ﬁnd appli-
cations as model analogues of certain metal enzymes (Khalil,
2010).
Prompted by the above ﬁndings and in continuation of our
study on exploring the biological proﬁle of Schiff bases (Ku-
mar et al., 2010, 2012; Judge et al., 2012a,b; Narang et al.,
2012a,b), we hereby report the synthesis, antimicrobial, anti-
cancer evaluation and QSAR studies of N0-benzylidene-4-(2-
oxo-2-(4H-1,2,4-triazol-4-yl)ethylamino)benzohydrazides.
2. Materials and methods
2.1. Instrumentation
Starting materials were obtained from commercial sources and
were used without further puriﬁcation. Reaction progress was
observed by thin layer chromatography making use of com-
mercial silica gel plates (Merck), Silica gel F254 on aluminum
sheets. Melting points were determined in open capillary tubes
on a Sonar melting point apparatus. 1H nuclear magnetic res-
onance (1H NMR) spectra were determined by Bruker Avance
II 400 NMR spectrometer in appropriate deuteriated solvents
and are expressed in parts per million (d, ppm) downﬁeld from
tetramethylsilane (internal standard). NMR data were given as
multiplicity (s, singlet; d, doublet; t, triplet; m, multiplet) and
number of protons. Infrared (IR) spectra were recorded on
an Agilent Resolutions Pro FTIR spectrometer. Elemental
analysis was performed on a Perkin–Elmer 2400 C, H and N
analyzer. Mass spectra were recorded using Waters Micromass
Q-Tof micro instrument.Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
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idene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-
oxopentylidene-4-(2-oxo-2-(4H-1,2,4-triazol-4-yl)ethylamino)
benzohydrazides
A mixture of 1,2,4-triazole (0.01 mol) and chloroacetyl chlo-
ride (0.01 mol) in absolute ethanol (20 ml) was reﬂuxed for
8–10 h. The contents were cooled and poured into ice cold
water. The separated product was ﬁltered, washed with water,
dried and recrystallized from ethanol to yield 2-chloro-1-(4H-
1,2,4- triazol-4-yl) ethanone triazole chloride. The later was
treated with p-amino benzoic acid (0.1 mol) in ether (50 ml)
maintained at 0–10 C temperature. The solution was stirred
for 30 min, the precipitated anilide was separated by ﬁltration,
which was then treated with 5% hydrochloric acid, 4% sodium
carbonate and water to remove residual aniline, and the resul-
tant anilide was recrystallized with alcohol (Mahiwal et al.,
2012). The above formed product (0.08 mol) was reﬂuxed with
ethanol (0.80 mol) in the presence of a few drops of concen-
trated sulfuric acid until completion of the reaction. The reac-
tion mixture was then added to 200 ml ice cold water and the
residual acid was removed by treatment with sodium bicarbon-
ate. The ester formed was extracted with ether and its evapo-
ration yielded the crude ester, which was recrystallized from
alcohol (Narang et al., 2012a). Hydrazine-hydrate (99%)
(0.015 mol) was added to ethanolic solution of ester
(0.01 mol) synthesized above and reﬂuxed for 8 h. The reaction
mixture was then cooled and the precipitated acid hydrazide
was ﬁltered off, washed with water, dried and recrystallized
from ethanol. The solution of acid hydrazide (0.01 mol) and
appropriate aldehyde (0.01 mol) in ethanol was reﬂuxed for
5–6 h. The precipitated title compounds were then ﬁltered
off, washed with water and recrystallized from ethanol (Nar-
ang et al., 2012a).
2.3. Evaluation of antimicrobial activity
The antimicrobial activity of the synthesized compounds was
performed against Gram-positive bacteria: Staphylococcus aur-
eus MTCC 2901, Bacillus subtilis MTCC 2063, Gram-negative
bacterium: Escherichia coli MTCC 1652 and fungal strains:
Candida albicans MTCC 227 and Aspergillus niger MTCC
8189 using tube dilution method (Cappucino and Sherman,
1999). Dilutions of test and standard compounds were pre-
pared in double strength nutrient broth – I.P. (bacteria) or
Sabouraud dextrose broth I.P. (fungi) (Pharmacopoeia of In-
dia, 2007). The samples were incubated at 37 C for 24 h (bac-
teria), at 25 C for 7 d (A. niger) and at 37 C for 48 h (C.
albicans), and the results were recorded in terms of MIC.
2.4. Evaluation of anticancer activity
The anticancer activity of the synthesized compounds (1–17)
was determined against human colon (HCT116) cancer cell
line. The cells were cultured in RPMI 1640 (Sigma) supple-
mented with 10% heat inactivated fetal bovine serum (FBS)
(PAA Laboratories) and 1% penicillin/streptomycin (PAA
Laboratories). Cultures were maintained in a humidiﬁed incu-
bator at 37 C in an atmosphere of 5% CO2. Anticancer activ-
ity of the synthesized compounds at various concentrations
was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
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Synthesis, antimicrobial, anticancer evaluation and QSAR studies 3tetrazolium bromide (MTT) (Sigma) assay, as described by
Mosmann, but with minor modiﬁcations, following 72 h of
incubation. Assay plates were read using a spectrophotometer
at 520 nm. Data generated were used to plot a dose–response
curve from which the concentration of test compounds re-
quired to kill 50% of cell population (IC50) was determined
(Mosmann, 1983).
2.5. QSAR studies
The structures of triazole derivatives (1–17) were ﬁrst pre-opti-
mized with the Molecular Mechanics Force Field (MM+) pro-
cedure included in Hyperchem 6.03 (Hyperchem, 1993) and the
resulting geometries were further reﬁned by means of the semi
empirical method PM3 (Parametric Method-3). We selected a
gradient norm limit of 0.01 kcal/A˚ for the geometry optimiza-
tion. The lowest energy structure of each molecule was used to
calculate physicochemical properties using TSAR (2000). Fur-
ther, the regression analysis was performed using the SPSS for
Windows (1999).
2.6. Cross-validation
The predictive powers of the equations were validated by leave
one out (LOO) cross-validation method (Schaper, 1999),
where a model is built with N1 compounds and Nth com-
pound is predicted. Each compound is left out of the model
derivation and predicted in turn. An indication of the perfor-
mance is obtained from cross-validated (or predictive q2) meth-
od which is deﬁned as
q2 ¼ 1 R YpredictedYactual
 2
= YactualYmeanð Þ
where Ypredicted, Yactual and Ymean are the predicted, actual and
mean values of target property (pMIC), respectively. R (Ypre-
dicted  Yactual)2 is the predictive residual error sum of squares.
3. Results and discussion
3.1. Chemistry
A series of N0-substituted benzylidene/2-hydroxynaphthalen-1-
ylmethylene/3-phenylallylidene/5-oxopentylidene-4-(2-oxo-2-
(4H-1,2,4-triazol-4-yl)ethylamino)benzo hydrazides (1–17) was
synthesized as outlined in Scheme 1. At ﬁrst, 1,2,4 triazole was
reacted with chloroacetyl chloride and the resultant product
was treated with p-amino benzoic acid to yield 4-(2-oxo-2-
(4H-1,2,4-triazol-4-yl)ethylamino)benzoic acid which was then
esteriﬁed using ethanol. The later on treatment with hydrazine
hydrate yielded hydrazide which on reaction with correspond-
ing aldehydes yielded the title products, N0-substituted benzyl-
idene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/
5-oxopentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl)ethyl-
amino)benzohydrazides (1–17). The physicochemical charac-
teristics of the synthesized compounds are presented in
Table 1. The structures of the synthesized compounds were
characterized by elemental analysis in addition to IR, NMR
and Mass spectroscopy and the spectral data were found in
agreement with the assigned molecular structures.Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
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The synthesized compounds were evaluated for their in vitro
antibacterial activity against S. aureus, B. subtilis, E. coli and
antifungal activity against C. albicans and A. niger by tube
dilution method using norﬂoxacin (antibacterial) and ﬂuconaz-
ole (antifungal) as reference standards and the results are pre-
sented in Table 2.
Among the synthesized compounds, 8 and 15 were found to
be effective against S. aureus (pMICca = 1.55 lM/mL) and C.
albicans (pMICca = 1.85 lM/mL), compound 15 emerged as
the most potent antibacterial agent (pMICbs = 1.55 lM/mL)
against for B. subtilis. In the case of Gram negative bacterium
E. coli, compound 8 was found to be the most potent with
pMICec values of 1.85 lM/mL (Table 2).
Antimicrobial screening revealed that the synthesized com-
pounds were found to be most potent against A. niger among
the panel of bacterial and fungal strains tested and compound
14 having electron releasing hydroxyl and methoxy groups was
found to be very effective against A. niger (pMI-
Can = 2.10 lM/mL) and was having antifungal potential com-
parable to the standard drug ﬂuconazole (pMICan = 2.64 lM/
mL). Thus, compound 14 may serve as an important lead in
the ﬁeld of antifungal research.
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N
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The in vitro anticancer activity of the synthesized 1,2,4 triazole
acid derivatives was determined against human colorectal can-
cer (HCT116) cancer cell line using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT) assay [23] and
the results are presented in Table 1.
Anticancer study indicated that the synthesized compounds
exhibited good anticancer potential. Compounds 1, 3, 7, 8, 9,
10 and 13 were found to be more potent than standard drug
carboplatin (IC50P 100 lM) but none of the synthesized com-
pounds exhibited anticancer potential better than that of 5-FU
(IC50 = 4.6 lM). Compound 7 (IC50 = 14.90 lM) was found
to be most potent anticancer agent against human colorectal
cancer (HCT116) cell line and may be taken as a new lead
for the development of novel anticancer agents. From the
results of anticancer and antimicrobial screening, it can be con-
cluded that electron-releasing group on benzylidene moiety im-
proved the antimicrobial as well as anticancer potential of the
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Comp. R R1 R2 R3 R4 R5
1 - H H Br H H 
2 - H H OH H H 
3 - H H Cl H H 
4 - H Cl H H H 
5 - Cl H H H H 
6 - H H OCH3 H H 
7 - H H CH3 H H 
8 - H OCH3 OCH3 OCH3 H 
9 - H OC2H5 OH H H 
10 - H H CHO H H 
11 - H H N(CH3)2 H H 
12 OH - - - - - 
13 - H H H H H 
14 - H OH OCH3 H H 
15 - H OCH3 OCH3 H H 
16 - - - - - 
17 O - - - - - 
Scheme 1 Scheme for the synthesis of 1,2,4-triazole derivatives.
4 S. Tahlan et al.3.4. QSAR studies
In order to identify the substituent effect on the antimicrobial
activity, quantitative structure–activity relationship (QSAR)
studies were undertaken, using the linear free energy relation-
ship model (LFER) described by Hansch and Fujita (1964).
Biological activity data determined as MIC values were ﬁrst
transformed into pMIC values (i.e. –log MIC) and used as a
dependent variable in the QSAR study. The values of selected
molecular descriptors used in the QSAR study are presented in
Table 3.
During the regression analysis studies compounds 2, 7, 8
and 14 were designated as outliers and were not included inPlease cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
zylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxo
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tistics, it is common to deﬁne three types of outliers (Furusjo
et al., 2006).
1. X/Y relation outliers are substances for which the relation-
ship between the descriptors (X variables) and the depen-
dent variables (Y variables) is not the same as in the (rest
of the) training data.
2. X outliers are substances whose molecular descriptors do
not lie in the same range as the (rest of the) training data.
3. Y outliers are only deﬁned for training or test samples.
They are substances for which the reference value of
response is invalid.ial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
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Table 1 Physicochemical characteristics and anticancer activity of the synthesized 1,2,4-triazole derivatives.
Comp. Mol. formula Mol. Wt. Rf Value
a M. pt. (C) % Yield HCT116 [IC50 (lM)]
1 C18H15N6O2Br 427 0.80 197–200 65.00 61.63
2 C18H16N6O3 364 0.62 247–250 46.00 152.79
3 C18H15N6O2Cl 384 0.62 165–168 61.50 78.17
4 C18H15N6O2Cl 383 0.84 112–115 42.30 171.55
5 C18H15N6O2Cl 383 0.84 114–117 82.00 148.90
6 C19H18N6O3 378 0.64 155–158 37.00 169.14
7 C19H18N6O3 362 0.80 137–140 31.40 14.90
8 C21H22N6O5 438 0.76 155–158 32.00 75.27
9 C20H20N6O4 408 0.80 177–180 70.20 68.56
10 C19H16N6O3 376 0.90 242–245 31.60 72.61
11 C20H21N7O2 391 0.70 232–235 49.00 131.13
12 C22H18N6O3 414 0.60 247–250 83.00 120.65
13 C18H16N6O2 348 0.70 75–79 88.00 66.02
14 C19H18N6O4 394 0.80 145–147 37.50 159.74
15 C20H20N6O6 440 0.80 170–173 92.00 124.88
16 C20H18N6O2 374 0.96 130–133 84.00 190.52
17 C16H18N6O3 342 0.82 225–228 32.40 106.12
5-FU 4.60
Carboplatin >100
a TLC mobile phase: *Chloroform: Toluene (7:3).
Table 2 Antimicrobial activity (pMIC in lM/mL) of the synthesized 1,2,4-triazole derivatives.
Comp pMICsa pMICbs pMICec pMICca pMICan pMICab pMICaf pMICam
1 1.23 1.23 1.53 1.23 1.53 1.33 1.38 1.35
2 1.16 1.16 1.46 1.16 1.16 1.26 1.16 1.22
3 1.49 1.49 1.79 1.49 1.49 1.59 1.49 1.55
4 1.49 1.19 1.49 1.49 1.79 1.39 1.64 1.49
5 1.49 1.49 1.79 1.49 1.79 1.59 1.64 1.61
6 1.48 1.18 1.78 1.78 1.78 1.48 1.78 1.60
7 1.46 1.16 1.76 1.76 2.06 1.46 1.91 1.64
8 1.55 1.24 1.85 1.85 1.85 1.55 1.85 1.67
9 1.51 1.21 1.51 1.51 1.51 1.41 1.51 1.45
10 1.48 1.48 1.48 1.78 1.78 1.48 1.78 1.60
11 1.50 1.50 1.50 1.80 1.50 1.50 1.65 1.56
12 1.52 1.22 1.52 1.82 1.52 1.42 1.67 1.52
13 1.45 1.45 1.45 1.75 2.05 1.45 1.90 1.63
14 1.50 1.50 1.80 1.80 2.10 1.60 1.95 1.74
15 1.55 1.55 1.55 1.85 1.55 1.55 1.70 1.61
16 1.48 1.48 1.78 1.78 2.08 1.58 1.93 1.72
17 1.44 1.44 1.74 1.74 2.04 1.54 1.89 1.68
S.D. 0.18 0.19 0.17 0.15 0.10 0.16 0.09 0.13
Std. 2.61a 2.61a 2.61a 2.64b 2.64b – – –
a Norﬂoxacin.
b Fluconazole.
Synthesis, antimicrobial, anticancer evaluation and QSAR studies 5Since there was no difference in the activity (Table 2) as well
as the molecular descriptor range (Table 3) of the outliers
when compared to other triazole derivatives indicated the fact
that these outliers belong to the category of Y outliers (Sub-
stances for which the reference value of response is invalid).
Our earlier studies (Kumar et al., 2012; Judge et al.,
2012a,b; Narang et al., 2012a,b) indicated that the multi-target
QSAR (mt-QSAR) models are better than one-target QSAR
(ot-QSAR) models in describing the antimicrobial activity.
Therefore, in the present study muti-target QSAR models were
developed to describe the antimicrobial activity of the synthe-Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
zylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxo
zohydrazides. Arabian Journal of Chemistry (2013), http://dx.doi.org/sized N0-benzylidene-4-(2-oxo-2-(4H-1,2,4-triazol-4-
yl)ethylamino)benzohydrazides.
According to the ot-QSAR models one should use ﬁve dif-
ferent equations with different errors to predict the activity of
a new compound against the ﬁve microbial species. The ot-
QSAR models, which are almost in the whole literature, be-
come impractical to use when each compound’s result must
be predicted for more than one target. In this case, one ot-
QSAR for each target needs to be developed. However, very
recently the interest has increased in the development of mul-
ti-target QSAR (mt- QSAR) models.ial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
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Table 3 Values of various descriptors used in the QSAR study.
Comp. log P MR 1vv 2vv 3vv J Te LUMO l
1 3.10 105.74 8.73 6.35 0.77 1.19 4742.07 0.69 0.85
2a 2.02 99.81 7.96 5.46 0.51 1.19 4722.98 0.73 5.08
3 2.82 102.92 8.33 5.89 0.64 1.19 4762.47 0.76 6.36
4 2.82 102.92 8.33 5.89 0.64 1.18 4762.56 0.64 1.11
5 2.82 102.92 8.34 5.83 0.60 1.20 4762.47 0.61 3.97
6 2.05 104.58 8.35 5.64 0.50 1.18 4878.36 0.67 1.45
7a 2.77 103.16 8.23 5.77 0.60 1.19 4558.35 0.65 1.25
8a 1.55 117.51 9.41 6.32 0.61 1.23 5829.69 0.76 6.67
9 2.11 111.02 9.08 6.02 0.56 1.19 5354.70 0.62 3.65
10 1.98 104.71 8.26 5.65 0.53 1.18 4850.70 0.93 2.40
11 2.10 111.82 8.85 6.35 0.73 1.18 4934.03 0.69 6.00
12 3.02 116.26 9.37 6.62 0.65 1.04 5262.58 0.83 2.04
13 2.31 98.12 7.82 5.27 0.44 1.19 4402.47 0.66 0.68
14a 1.77 106.27 8.49 5.80 0.56 1.19 5198.92 0.63 3.46
15 2.34 113.74 9.21 6.07 0.55 1.20 5988.88 0.74 4.66
16 2.71 108.36 8.49 5.65 0.44 1.15 4685.83 0.67 2.29
17 0.22 91.75 7.68 5.01 0.34 1.46 4495.33 0.68 2.16
a Outliers.
6 S. Tahlan et al.In opposition to ot-QSAR, the mt-QSAR model is a single
equation that considers the nature of molecular descriptors
that are common and essential for describing the antibacterial
and antifungal activities (Gonzalez-Diaz and Prado-Prado,
2008; Cruz-Monteagudo et al., 2007; Gonzalez-Diaz et al.,
2007; Prado-Prado et al., 2008). In light of the above, we at-
tempted to develop three different mt-QSAR models viz. mt-
QSAR model for describing antibacterial activity of synthe-
sized compounds against S. aureus, B. subtilis and E. coli,
mt-QSAR model for describing antifungal activity of synthe-
sized compounds against C. albicans and A. niger as well as
a common mt-QSAR model for describing the antimicrobial
(overall antibacterial and antifungal) activity of the synthe-
sized compounds against all of the above mentioned
microorganisms.
In order to develop mt-QSAR models, initially we calcu-
lated the average antibacterial, antifungal and antimicrobial
activities of 1,2,4-triazole derivatives which are presented in
Table 2. Preliminary analysis was carried out in terms of
correlation analysis. A correlation matrix constructed for
antibacterial activity is presented in Table 4. In general, high
colinearity (r> 0.5) was observed between different parame-Table 4 Correlation matrix for antibacterial activity of the synthes
log P MR 3v j1 J W
log P 1.000 0.563 0.659 0.108 0.864
MR 1.000 0.544 0.815 0.752
3v 1.000 0.182 0.529
j1 1.000 0.312
J 1.000 
W
Te
LUMO
HOMO
l
pMICab
Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
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ﬁrst order shape index (j1) and W (r= 0.973), and low inter-
relationship was observed between Balaban index (J) and di-
pole moment (l) (r= 0.006, Table 4).
The antibacterial activity of 1,2,4-triazole derivatives is best
described by the electronic parameter, dipole moment (l)
(r= 0.592, Table 4, Eq. (1)).
3.4.1. LR mt-QSAR model for antibacterial activity
pMICab ¼ 0:026lþ 1:41
n ¼ 13 r ¼ 0:592 q2 ¼ 0:124 s ¼ 0:069 F ¼ 5:94 ð1Þ
Here and thereafter, n – number of data points, r – correlation
coefﬁcient, q2 – cross validated r2 obtained by leave one out
method, s – standard error of the estimate and F – Fischer
statistics.
Coefﬁcient of l in Eq. (1) is positive which indicates that
antibacterial activity of the synthesized 1,2,4-triazoles is posi-
tively correlated with their l values, i.e., antibacterial activity
of 1,2,4-triazoles will decrease with decrease in their l values
and vice versa. This is evidenced by low antibacterial activityized 1,2,4-triazole derivatives.
Te LUMO HOMO l pMICab
0.276 0.194 0.015 0.206 0.031 0.227
0.906 0.766 0.243 0.696 0.320 0.157
0.264 0.252 0.099 0.348 0.287 0.420
0.973 0.963 0.219 0.542 0.403 0.037
0.507 0.312 0.251 0.457 0.006 0.270
1.000 0.937 0.285 0.589 0.344 0.021
1.000 0.207 0.383 0.382 0.006
1.000 0.071 0.070 0.002
1.000 0.421 0.024
1.000 0.592
1.000
ial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
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Table 5 Observed, predicted and residual antimicrobial activities of the synthesized 1,2,4-triazole derivatives.
Comp. pMICab pMICaf pMICam
Obs. Pre. Res. Obs. Pre. Res. Obs. Pre. Res.
1 1.33 1.33 0.00 1.38 1.46 0.08 1.35 1.39 0.04
2 1.26 1.59 0.33 1.16 1.75 0.59 1.22 1.65 0.43
3 1.59 1.58 0.01 1.49 1.61 0.12 1.55 1.58 0.03
4 1.39 1.40 0.01 1.64 1.61 0.03 1.49 1.49 0.00
5 1.59 1.51 0.08 1.64 1.66 0.02 1.61 1.57 0.04
6 1.48 1.46 0.02 1.78 1.76 0.02 1.60 1.59 0.01
7 1.46 1.41 0.05 1.91 1.65 0.26 1.64 1.51 0.13
8 1.55 1.60 0.05 1.85 1.65 0.20 1.67 1.61 0.06
9 1.41 1.52 0.11 1.51 1.70 0.19 1.45 1.59 0.14
10 1.48 1.48 0.00 1.78 1.73 0.05 1.60 1.58 0.02
11 1.50 1.52 0.02 1.65 1.50 0.15 1.56 1.51 0.05
12 1.42 1.42 0.00 1.67 1.59 0.08 1.52 1.49 0.03
13 1.45 1.47 0.02 1.90 1.84 0.06 1.63 1.62 0.01
14 1.60 1.51 0.09 1.95 1.70 0.25 1.74 1.58 0.16
15 1.55 1.55 0.00 1.70 1.71 0.01 1.61 1.61 0.00
16 1.58 1.52 0.06 1.93 1.84 0.09 1.72 1.65 0.07
17 1.54 1.56 0.02 1.89 1.95 0.06 1.68 1.72 0.04
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Figure 1 Plot of predicted pMICab vs. observed pMICab by Eq.
(2).
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Figure 2 Plot of observed pMICab vs. residual pMICab by Eq.
(2).
Synthesis, antimicrobial, anticancer evaluation and QSAR studies 7of compound 1 (pMICab = 1.33, Table 2) having low l value
(0.85, Table 3).
Coupling of dipole moment with topological parameter, va-
lence third order molecular connectivity index (3vv) resulted in
the best QSAR model for explaining antibacterial activity (Eq.
(2)) of the synthesized compounds which was having a remark-
able improvement in the r and q2 values from 0.592 to 0.855
and 0.124 to 0.640 respectively.
3.4.2. MLR mt-QSAR model for antibacterial activity
pMICab ¼ 0:4383vv þ 0:034lþ 1:636
n ¼ 13 r ¼ 0:855 q2 ¼ 0:640 s ¼ 0:047 F ¼ 13:53 ð2Þ
The molecular connectivity index, an adjacency based topo-
logical index proposed by Randic is denoted by v and is de-
ﬁned as sum over all the edges (ij) as per following:
v ¼
Xn
i¼l
Vi Vjð Þ1=2
where Vi and Vj are the degrees of adjacent vertices i and j and
n is the number of vertices in a hydrogen suppressed molecular
structure (Lather and Madan, 2005). The topological index, v
signiﬁes the degree of branching, connectivity of atoms and
unsaturation in the molecule that accounts for variation in
activity (Gupta et al., 2003).
The QSAR model expressed by Eq. (2) was cross validated
by its high q2 value (q2 = 0.640) obtained by leave one out
(LOO) method. The value of q2 greater than 0.5 is the basic
requirement for qualifying a QSAR model to be a valid one
(Golbraikh and Tropsha, 2002). As the observed and predicted
values are close to each other (Table 5), the mt-QSAR model
for antibacterial activity (Eq. (2)) is valid. The plot of predicted
pMICab against observed pMICab (Fig. 1) also favors the
developed model expressed by Eq. (2). Further, the plot of ob-
served pMICab vs residual pMICab (Fig. 2) indicated that there
was no systemic error in model development as the propaga-
tion of error was observed on both sides of zero (Kumar
et al., 2007).Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrobial, anticancer evaluation and QSAR studies ofN0-substituted ben-
zylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxopentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
zohydrazides. Arabian Journal of Chemistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.07.029
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Figure 3 Plot of observed pMICam against predicted pMICam by
Eq. (5).
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Figure 4 Plot of observed pMICam against residual pMICam by
Eq. (5).
8 S. Tahlan et al.Topological parameter, valence third order molecular con-
nectivity index (3vv) was the most effective in describing anti-
fungal activity of the synthesized compounds (Eq. 3).
3.4.3. LR-mt-QSAR model for antifungal activity
pMICaf ¼ 1:1333vv þ 2:333
n ¼ 13 r ¼ 0:828 q2 ¼ 0:548 s ¼ 0:098 F ¼ 23:89 ð3Þ
The coefﬁcient of 3vv in Eq. (3) is negative which signiﬁes
that the antifungal activity of the synthesized compounds is
negatively correlated to 3vv. This is evidenced by the antifungal
activity data of the synthesized 1,2,4-triazole derivatives (Ta-
ble 2) and their 3vv values (Table 3).
The mt-QSAR model of antimicrobial activity (Eq. 4) also
depicted the importance of topological parameter, valence
third order molecular connectivity index (3vv) in describing
antimicrobial activity of the synthesized compounds.
3.4.4. MLR-mt-QSAR model for antimicrobial activity
pMICam ¼ 0:6253vv þ 1:922
n ¼ 13 r ¼ 0:777 q2 ¼ 0:402 s ¼ 0:064 F ¼ 16:72 ð4Þ
Further, in search of a better QSAR model, we coupled
topological parameter, valence third order molecular connec-
tivity index (3vv) with electronic parameter, dipole moment
(l) and this change resulted in a signiﬁcant improvement of
the r value (r= 0.842, Eq. (5)) as well as q2 value (q2 = 0.530).
3.4.5. MLR mt-QSAR model for antimicrobial activity
pMICam ¼ 0:7033vv þ 0:017lþ 1:916
n ¼ 13 r ¼ 0:842 q2 ¼ 0:530 s ¼ 0:058 F ¼ 12:17 ð5Þ
Validity of developed QSAR models for antifungal and
antimicrobial activities was conﬁrmed by their high q2 values
(0.548 and 0.530, respectively) as well as low residual values
(Table 5). The plot of predicted pMICam against observed
pMICam (Fig. 3) also favors the developed model expressed
by Eq. (5).Please cite this article in press as: Tahlan, S. et al., Synthesis, antimicrob
zylidene/2-hydroxynaphthalen-1-ylmethylene/3-phenylallylidene/5-oxo
zohydrazides. Arabian Journal of Chemistry (2013), http://dx.doi.org/Further, the plot of observed pMICam vs. residual pMICam
(Fig. 4) indicated that there was no systemic error in model
development as the propagation of error was observed on both
sides of zero (Kumar et al., 2007). The high residual value (Ta-
ble 5) observed in case of outliers (2, 7, 8 and 14) justiﬁed their
removal as outliers.
In summary, the mt-QSAR models [Eqs. (1–5)] indicated
that antimicrobial activity of the synthesized 1,2,4-triazole
derivatives is governed by the topological parameter, valence
third order molecular connectivity index ð3vv) and electronic
parameter, dipole moment (l).
Generally for QSAR studies, the biological activities of
compounds should span 2–3 orders of magnitude. But in the
present study the range of antimicrobial activities of the syn-
thesized compounds was within one order of magnitude. This
is in accordance with results suggested by Bajaj et al. (2005)
who stated that the reliability of the QSAR model lies in its
predictive ability even though the activity data are within a
narrow range (Bajaj et al., 2005). When biological activity data
lie in the narrow range, the presence of minimum standard
deviation of the biological activity justiﬁes its use in QSAR
studies (Narasimhan et al., 2007). The minimum standard
deviation (Table 2) observed in the antimicrobial activity data
justiﬁes its use in QSAR studies.
4. Conclusion
In order to develop novel antimicrobial and anticancer com-
pounds, a series of 1,2,4-triazole derivatives was synthesized
and characterized by physicochemical and spectral means.
The synthesized compounds were evaluated for their antimi-
crobial and anticancer potentials. The synthesized compounds
were found to be more potent against A. niger than other bac-
terial and fungal strains tested. Compound 14 (pMI-
Can = 2.10 lM/ml) having antifungal activity comparable to
the standard drug ﬂuconazole was found to be the most potent
antifungal agent. Besides having good antimicrobial activity,
the synthesized compounds were having appreciable antican-
cer activity. Compound 7 (IC50 = 14.90 lM) was found to
be the most potent anticancer agent. QSAR studies for antimi-ial, anticancer evaluation and QSAR studies ofN0-substituted ben-
pentylidene -4-(2-oxo-2-(4H-1,2,4-triazol-4-yl) methylamino)ben-
10.1016/j.arabjc.2013.07.029
Synthesis, antimicrobial, anticancer evaluation and QSAR studies 9crobial activity of the synthesized compounds indicated that
antimicrobial activity of the synthesized 1,2,4-triazole deriva-
tives was governed by topological parameter, valence third or-
der molecular connectivity index (3vv) and electronic
parameter, dipole moment (l).Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/
j.arabjc.2013.07.029.
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